OI
BMY icon

Oakbrook Investments’s Bristol-Myers Squibb BMY Stock Holding History

Oakbrook Investments’s Portfolio BMY Stock Details BMY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q1 		– Sell
-24,718
Closed -$1.59M – 140
2019
Q4 		$1.59M Sell
24,718
-20,761
-46% -$1.19M 0.32% 50
2019
Q3 		$2.31M Sell
45,479
-10,400
-19% -$489K 0.15% 91
2019
Q2 		$2.53M Sell
55,879
-2,085
-4% -$97.1K 0.15% 92
2019
Q1 		$2.77M Sell
57,964
-37,240
-39% -$1.86M 0.17% 97
2018
Q4 		$4.95M Buy
95,204
+12,510
+15% +$672K 0.34% 55
2018
Q3 		$5.13M Buy
82,694
+50
+0.1% +$2.97K 0.28% 62
2018
Q2 		$4.57M Sell
82,644
-9,610
-10% -$519K 0.29% 62
2018
Q1 		$5.83M Buy
92,254
+13,420
+17% +$863K 0.36% 53
2017
Q4 		$4.83M Sell
78,834
-15,370
-16% -$961K 0.31% 59
2017
Q3 		$6M Sell
94,204
-10,450
-10% -$610K 0.39% 48
2017
Q2 		$5.83M Sell
104,654
-4,350
-4% -$237K 0.39% 51
2017
Q1 		$5.93M Buy
109,004
+3,900
+4% +$214K 0.39% 56
2016
Q4 		$6.14M Buy
105,104
+10,200
+11% +$558K 0.4% 53
2016
Q3 		$5.12M Buy
94,904
+64,300
+210% +$4.13M 0.31% 67
2016
Q2 		$2.25M Buy
30,604
+5,000
+20% +$353K 0.12% 154
2016
Q1 		$1.64M Sell
25,604
-2,900
-10% -$183K 0.11% 159
2015
Q4 		$1.96M Buy
28,504
+1,108
+4% +$73.2K 0.13% 144
2015
Q3 		$1.62M Sell
27,396
-76,888
-74% -$4.88M 0.11% 175
2015
Q2 		$6.94M Sell
104,284
-102,963
-50% -$6.79M 0.42% 57
2015
Q1 		$13.4M Buy
207,247
+80,250
+63% +$5.02M 0.72% 35
2014
Q4 		$7.5M Sell
126,997
-116,600
-48% -$6.58M 0.4% 53
2014
Q3 		$12.5M Sell
243,597
-253,800
-51% -$12.7M 0.67% 39
2014
Q2 		$24.1M Buy
497,397
+42,200
+9% +$2.08M 0.73% 34
2014
Q1 		$23.6M Sell
455,197
-100,200
-18% -$5.33M 0.75% 33
2013
Q4 		$29.5M Buy
555,397
+9,843
+2% +$501K 0.82% 29
2013
Q3 		$25.2M Buy
545,554
+202,804
+59% +$8.9M 0.74% 37
2013
Q2 		$15.3M Buy
+342,750
New +$14.9M 0.44% 56

Other funds holding BMY

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Dodge & Cox
Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return

Oakbrook Investments's BMY Position: Q1 2020 in Review

Oakbrook Investments sold out of Bristol-Myers Squibb (BMY) in Q1 2020, closing a stake of 24,718 shares — an estimated $1.59M sold.

Oakbrook Investments first reported a position in BMY in Q2 2013 and held it in 27 quarters. The position peaked at $29.5M in Q4 2013. 2,147 funds tracked by Wall St. Rank hold BMY as of Q1 2020.

  • Oakbrook Investments reported no remaining Bristol-Myers Squibb position as of Q1 2020 after selling out during the quarter.
  • Oakbrook Investments sold 24,718 Bristol-Myers Squibb shares in Q1 2020, an estimated $1.59M.
  • Oakbrook Investments first reported a position in Bristol-Myers Squibb in Q2 2013 and held it in 27 quarters.
  • Oakbrook Investments's Bristol-Myers Squibb position peaked at $29.5M in Q4 2013.
  • 2,147 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q1 2020.

Based on Oakbrook Investments's 13F filing for Q1 2020, filed 22 Apr 2020.